Crossvault Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3.28M | Sell |
22,979
-950
| -4% | -$136K | 1.29% | 26 |
|
|
2022
Q1 | $4.12M | Sell |
23,929
-2,283
| -9% | -$393K | 1.33% | 27 |
|
|
2021
Q4 | $6.66M | Buy |
26,212
+3,279
| +14% | +$833K | 2% | 22 |
|
|
2021
Q3 | $8.83M | Buy |
22,933
+4,258
| +23% | +$1.64M | 2.78% | 14 |
|
|
2021
Q2 | $6.6M | Buy |
18,675
+3,290
| +21% | +$1.16M | 2.01% | 24 |
|
|
2021
Q1 | $2.02M | Buy |
+15,385
| New | +$2.02M | 0.72% | 38 |
|